Understanding Phenytoin Therapy - Clinical Pharmacokinetics and Serum Concentrations
Phenytoin, a medication with high protein binding and hepatic metabolism, exhibits saturated pharmacokinetics with a narrow therapeutic range of 10-20 µg/mL for total serum concentrations. Adverse effects vary with serum levels: minor CNS depression at >15 µg/mL, nystagmus at >20 µg/mL, and ataxi
0 views • 55 slides
Understanding Wernicke-Korsakoff Syndrome: Overview and Clinical Considerations
Wernicke-Korsakoff Syndrome (WKS) comprises Wernicke's Encephalopathy (WE) and Korsakoff Syndrome. WE presents with altered mental status, ocular signs, and ataxia, while Korsakoff Syndrome manifests as amnesia and confabulations. Untreated WE can progress to Korsakoff Syndrome in about 80% of cases
0 views • 52 slides
Understanding Vitamin E Deficiency in Poultry: Symptoms and Implications
Vitamin E deficiency in poultry can lead to serious conditions such as encephalomalacia (crazy chick disease) and exudative diathesis. Symptoms include ataxia, testicular degeneration, and early embryo mortality. Post-mortem lesions show soft and swollen brains with minute hemorrhages. It is crucial
0 views • 14 slides
Coping with Ataxia: Strategies and Support for Living Well
Charlotte DePew shares her personal journey with Friedreich's ataxia, offering insights into coping mechanisms, emotional stages, and practical tips for managing the progressive condition. From grieving to finding feel-good activities, this comprehensive guide empowers individuals to navigate life w
0 views • 12 slides
Evaluation of Genetic Abnormalities in a 45-Year-Old Male with Gait Abnormalities
A 45-year-old male with gait abnormalities was referred for evaluation, with an unknown inheritance and deceased parents. His father had a history of ataxia and tremor. Using the GAIN scoring metric, the genomic content was assessed, including the presence of protein-coding genes, established TS gen
0 views • 24 slides
NAF Supported Research Funding Update by Dr. Harry T. Orr, PhD
This update provides insights into the National Ataxia Foundation's mission to support ataxia research by funding new investigators and treatments. It details funded research in 2015 and 2016, including seed grants, SCA pioneer grants, and grants for young investigators. The focus is on fostering ad
0 views • 16 slides